New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials ...Middle East

PR Newswire - News
New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
After achieving primary endpoint by demonstrating non-inferiority in HbA1C reduction from baseline at week 52, investigative insulin icodec helped patients achieve significantly more time in target blood glucose range (Time in Range) vs. once-daily basal insulin glargine U100 in ONWARDS...

Hence then, the article about new data show once weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News